1-[(3S,4R)-4-(4-chloro-2,6-difluoro-phenyl)-2-oxo-pyrrolidin-3-yl]-3-[1-(6-methyl-2-pyridyl)cyclopropyl]urea

ID: ALA5281612

Max Phase: Preclinical

Molecular Formula: C20H19ClF2N4O2

Molecular Weight: 420.85

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(C2(NC(=O)N[C@@H]3C(=O)NC[C@H]3c3c(F)cc(Cl)cc3F)CC2)n1

Standard InChI:  InChI=1S/C20H19ClF2N4O2/c1-10-3-2-4-15(25-10)20(5-6-20)27-19(29)26-17-12(9-24-18(17)28)16-13(22)7-11(21)8-14(16)23/h2-4,7-8,12,17H,5-6,9H2,1H3,(H,24,28)(H2,26,27,29)/t12-,17-/m0/s1

Standard InChI Key:  VVUALUDYBZOYKM-SJCJKPOMSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   -1.8882    0.6466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1737    1.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4591    0.6465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2554    1.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9701    0.6465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2554    1.8843    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6847    1.0591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7710    1.8794    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5778    2.0509    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9902    1.3366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4382    0.7236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6518   -0.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4489   -0.2872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6611   -1.0821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0774   -1.6658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2839   -1.4548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0658   -0.6594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1874    2.4629    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7604    1.7751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5855    1.7751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8884   -0.1785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6013   -0.5892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3161   -0.1765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3177    0.6445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6059    1.0610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0324    1.0571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0324    0.2962    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.2687   -0.4458    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.2910   -2.4629    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  7  5  1  6
  8  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
 11 12  1  1
 13 12  2  0
 14 13  1  0
 15 14  2  0
 16 15  1  0
 12 17  1  0
 17 16  2  0
  8 18  2  0
  2 19  1  0
 19 20  1  0
  2 20  1  0
 21  1  2  0
 22 21  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
  1 25  1  0
 24 26  1  0
 13 27  1  0
 17 28  1  0
 15 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5281612

    ---

Associated Targets(Human)

FPR2 Tchem Lipoxin A4 receptor (3472 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR1 Tchem Formyl peptide receptor 1 (1372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.85Molecular Weight (Monoisotopic): 420.1165AlogP: 2.89#Rotatable Bonds: 4
Polar Surface Area: 83.12Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.72CX Basic pKa: 4.66CX LogP: 1.99CX LogD: 1.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.71Np Likeness Score: -0.83

References

1. Maciuszek M, Cacace A, Brennan E, Godson C, Chapman TM..  (2021)  Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential.,  213  [PMID:33486199] [10.1016/j.ejmech.2021.113167]

Source